Aurobindo Pharma Limited (AUROPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aurobindo Pharma Limited (NSE: AUROPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹1,734.00, market capitalisation ₹99,771 Cr, P/E 26.4, ROE 10.1%.
Get the AI verdict on AUROPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
AUROPHARMA price and valuation
- Share price
- ₹1,734.00
- Market cap
- ₹99,771 Cr
- P/E ratio
- 26.4
- P/B ratio
- 2.66
- EPS
- ₹64.09
- Book value per share
- ₹652.00
- Dividend yield
- 0.23%
AUROPHARMA profitability and growth
- ROE
- 10.1%
- ROCE
- 12.9%
- Debt to equity
- 0.21
- Revenue growth (3 yr)
- 11%
- Revenue growth (5 yr)
- 6%
- Profit growth (3 yr)
- 23%
- Profit growth (5 yr)
- 1%
AUROPHARMA 52-week range
- 52-week high
- ₹1,734.00
- 52-week low
- ₹1,066.80
- Face value
- ₹1.00
AUROPHARMA shareholding pattern
- Promoters
- 51.88%
- FIIs
- 16.38%
- DIIs
- 25.05%
- Public
- 6.63%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.